A woman has come forward claiming to be a Pfizer whistleblower with a helluva story to tell about the pharmaceutical giant.

Predictably, the result of this communication has been calamitous for patients: many of those returning to our obesity clinic ...

THE US Food and Drug Administration approved Pfizer’s gene therapy for hemophilia B on Friday (Apr 26), the second such therapy for the rare bleeding disorder that typically requires regular infusions ...

Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech are being dragged into another round of mRNA litigation by GSK.

(Adds price of rival therapy in paragraph 5, expert comment in paragraph 8) By Sriparna Roy April 26 (Reuters) - The U.S. Food and Drug Administration approved Pfizer's gene therapy for hemophilia B ...

The Food and Drug Administration on Friday approved a new gene therapy for hemophilia, clearing Pfizer’s Beqvez for certain people with the less common “B” form of the bleeding condition.

The collaboration aims to develop a first-of-its-kind digital PCR assay capable of detecting and quantifying minimal amounts of DNA with high accuracy. The results add to an early but growing ...

For undocumented Latinx patients who sought care in the emergency room during the pandemic, the reported rate of having received the COVID-19 vaccine was found to be the same as U.S. citizens ...

Sign up for our Metro US email newsletter to get news, updates, and local insights delivered straight to your inbox! PUTUCUAL, Venezuela (AP) — Some of the 10 women ...

Pfizer made $11.2 billion in sales from Comirnaty last year, while Moderna earned $6.7 billion from its vaccine Spikevax ... Product Liabilitycategory US FDA advises healthcare facilities to ...

Unplug These 29 Items That Hike Up Your Electricity Bill Why Donald Trump Didn’t Sink Mike Johnson’s Ukraine-Aid Bill Social Security: How the Average Retiree Can Get an Extra $1,071 per ...

During a busy period of overhaul at Sanofi, the company is restructuring its U.S. vaccine commercial group. The company is "implementing a streamlined strategic sales structure" as the U.S ...